Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Boersma

Showing results (11-20 of 757) with videos related to

Pageof 76
Sort By:
Expert Review of Cardiovascular Therapy|June 12, 2013
The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a reviewRoberto Ferrari, Eric Boersma
The New England Journal of Medicine|July 29, 2005
Beta-blocker therapy in noncardiac surgeryDon Poldermans, Eric Boersma
European Heart Journal. Digital Health|January 30, 2023
Real-time handling of missing predictorsEric Boersma, Isabella Kardys
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 21, 2016
What determines low troponin concentrations in stable patients?Eric Boersma, K Martijn Akkerhuis
Current Opinion in Investigational Drugs (London, England : 2000)|April 16, 2004
Intravenous glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: lessons from recently conducted randomized clinical trialsEric Boersma, Cynthia M Westerhout
Expert Opinion on Drug Safety|August 9, 2003
Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromesCynthia M Westerhout, Eric Boersma
European Journal of Epidemiology|May 11, 2024
The perpetual need of randomized clinical trials: challenges and uncertainties in emulating the REDUCE-AMI trialMaarten J G Leening, Eric Boersma
The New England Journal of Medicine|October 4, 2002
Small abdominal aortic aneurysmsMiklos D Kertai, Eric Boersma, Don Poldermans
Statistics in Medicine|February 2, 2019
Joint models for longitudinal and time-to-event data in a case-cohort designSara J Baart, Eric Boersma, Dimitris Rizopoulos
Expert Review of Cardiovascular Therapy|April 12, 2008
Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease managementRohit M Oemrawsingh, K Martijn Akkerhuis, Eric Boersma
Pageof 76

Showing results (11-20 of 757) with videos related to

Sort By:
Pageof 76
Expert Review of Cardiovascular Therapy|June 12, 2013
The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a reviewRoberto Ferrari, Eric Boersma
The New England Journal of Medicine|July 29, 2005
Beta-blocker therapy in noncardiac surgeryDon Poldermans, Eric Boersma
European Heart Journal. Digital Health|January 30, 2023
Real-time handling of missing predictorsEric Boersma, Isabella Kardys
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 21, 2016
What determines low troponin concentrations in stable patients?Eric Boersma, K Martijn Akkerhuis
Current Opinion in Investigational Drugs (London, England : 2000)|April 16, 2004
Intravenous glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: lessons from recently conducted randomized clinical trialsEric Boersma, Cynthia M Westerhout
Expert Opinion on Drug Safety|August 9, 2003
Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromesCynthia M Westerhout, Eric Boersma
European Journal of Epidemiology|May 11, 2024
The perpetual need of randomized clinical trials: challenges and uncertainties in emulating the REDUCE-AMI trialMaarten J G Leening, Eric Boersma
The New England Journal of Medicine|October 4, 2002
Small abdominal aortic aneurysmsMiklos D Kertai, Eric Boersma, Don Poldermans
Statistics in Medicine|February 2, 2019
Joint models for longitudinal and time-to-event data in a case-cohort designSara J Baart, Eric Boersma, Dimitris Rizopoulos
Expert Review of Cardiovascular Therapy|April 12, 2008
Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease managementRohit M Oemrawsingh, K Martijn Akkerhuis, Eric Boersma
Pageof 76